1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Osteoarthritis Therapeutics: Global Markets

Osteoarthritis Therapeutics: Global Markets

  • January 2022
  • 133 pages
  • ID: 6219714
  • Format: PDF
  • BCC Research


Table of Contents

Report Scope:
This report provides a detailed description of the approaches used to treat pain management associated with osteoarthritis and the latest updates in the market. The report includes market estimates for different types of drugs and therapies used to treat osteoarthritis.

Based on anatomy, the osteoarthritis therapeutics market is segmented into knee osteoarthritis, hip osteoarthritis, others (shoulder, hand and small joint osteoarthritis).

Based on drug type, the osteoarthritis therapeutics market is segmented as viscosupplementation agents; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) including ibuprofen, aspirin, diclofenac, naproxen, and other NSAIDs; analgesics; and corticosteroids.

Based on route of administration, the osteoarthritis therapeutics market is segmented into parenteral route, oral route and topical route.

Based on drug classification, the osteoarthritis therapeutics market is segmented into prescription drugs and over-the-counter (OTC) drugs.

The report discusses the qualitative and quantitative factors influencing market growth. Market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the global osteoarthritis therapeutics market, as well as the competition and the key players’ strategies and performances.The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions.

The report also includes company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report provides insights on market shares and upcoming regional demand for osteoarthritis therapeutics.

Some of the major market players discussed in the report are Sanofi S.A., Fidia Farmaceutici S.p.A, Seikagaku Corp., Anika Therapeutics Inc., Pfizer Inc. and GlaxoSmithKline PLC. For market estimates, data has been provided for 2020, which serves as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:
- 27 data tables and 33 additional tables
- An overview of the global market for osteoarthritis therapeutics
- Estimation of the market size and analyses of global market trends, with data from 2019 to 2020, estimates for 2021 with projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the market potential for osteoarthritis therapeutics, based on type of anatomy, drug type, route of administration, purchasing pattern and region
- Discussion on recent developments of agents for the treatment of OA, which includes potential disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics for pain relief
- Description of pharmacological and non-pharmacological methods of OA management and information on personalized medicines for OA
- Discussion on the risk of adverse cardiovascular events related to the use of NSAIDs in osteoarthritis
- Coverage of clinical trials and applications of attractive drugs in preclinical research; regulatory scenarios, ongoing research on anti-NGF therapy and government expenditures
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players, including Abbott Laboratories Inc., Bayer AG, Eli Lilly and Co., GlaxoSmithKline PLC, Pfizer Inc. and Sanofi.

The global market for osteoarthritis therapeuticswasworth REDACTED in 2020.The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach REDACTED by 2026.

The growing geriatric population, rising incidence of OA and growing demand forminimally invasive surgical procedures are driving the global osteoarthritis therapeuticsmarket.Osteoarthritis is the most common type of arthritis, characterized by pain, swelling and restricted jointmotion. The knees, hips and shoulder are the most common joints affected by osteoarthritis. Cartilage, a slippery tissue that covers up the ends of bones in a joint, gets damaged as a result of osteoarthritis.OAwidely occurs in the elderly population and thosewho are obese.

Reasons for Doing This Study:
Osteoarthritis is a musculoskeletal disease resulting from the breakdown of joint cartilage and the underlying bone.It is a common musculoskeletal condition and a long-term, chronic disease.

The common symptoms of osteoarthritis are joint pain and stiffness.Knee osteoarthritis is, in particular, a major cause of disability.

As people age, bone cell production and the fluid present in knee joints both decrease, thereby increasing the friction between two joints. This condition results in bones rubbing together and creating stiffness, pain and impaired movement. Osteoarthritis is associated with a wide range of modifiable and non-modifiable risk factors: obesity, lack of exercise, bone density, genetic
predisposition, occupational injury, trauma and gender. The different treatment types for osteoarthritis
- Joint replacement surgery: An invasive replacement surgery that is costlier than viscosupplementation.
- Pharmacological treatment: Nonsteroidal anti-inflammatory drugs (NSAIDs), topical NSAIDs,symptomatic slow-acting drugs (SYSADOA), psychotropic drugs, opioid analgesics, COX-2inhibitors and topical capsaicin for the treatment of osteoarthritis.
- Intra-articular treatment: Corticosteroids, hyaluronans and tidal irrigation medicines.
- Surgery: Arthroscopy, osteotomy and noncompartmental knee replacement surgeries.
- Non-pharmacological treatments: Acupuncture, herbal therapies, weight loss, orthodontic device treatment and physical therapies.
- Viscosupplementation: A minimally invasive treatment for knee osteoarthritis. It involves the injection of hyaluronic acid into the knee joint to add viscous properties to remaining synovial fluid. This procedure increases joint functioning and reduces pain. Intra-articular viscosupplementation with hyaluronic acid is gaining acceptance as a noninvasive procedure compared to knee replacement. Viscosupplementation is categorized into three product segments: single-injection cycle, three-injection cycle and five-injection cycle.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Auto-Injectors Market Research Report by Therapy, Product Type, End-user, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 2949
  • April 2022
  • 112 pages

Auto-Injectors Market Research Report by Therapy (Anaphylaxis, Diabetes, and Multiple Sclerosis), Product Type, End-user, Application, State (California, Texas, and Ohio) - United States Forecast to 2027 ...

  • United States
  • Neurological Disorder
  • Arthritis
  • Industry analysis


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on